With approval, the HeartMate 3 System offers physicians in Europe the most advanced ventricular assist technology available to support the management of patients with advanced stage heart failure ST.
MOMENTUM 3 Study meets primary endpoint for short-term indication Results presented during late-breaking clinical trial session at the AHA Scientific Sessions MOMENTUM 3 Study data published in the ...
St. Jude Medical, Inc, a global medical device company, on Tuesday announced approval and launch of the HeartMate 3™ Left Ventricular Assist System (LVAS) in India. "The HeartMate 3 system allows me ...
Abbott has received US Food and Drug Administration (FDA) approval for its Full MagLev HeartMate 3 Left Ventricular Assist System (also known as an LVAD). The HeartMate 3 system provides a new option ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results